Please use this identifier to cite or link to this item:
|Title:||Procalcitonin in severe acute respiratory syndrome (SARS)||Authors:||Chua, A.P.
Severe acute respiratory
|Issue Date:||2004||Citation:||Chua, A.P., Lee, K.H. (2004). Procalcitonin in severe acute respiratory syndrome (SARS). Journal of Infection 48 (4) : 303-306. ScholarBank@NUS Repository. https://doi.org/10.1016/j.jinf.2004.01.015||Abstract:||Objective and methods. The role of procalcitonin (PCT) in severe acute respiratory syndrome (SARS) has not been highlighted so far. We described retrospectively eight cases of sepsis from pneumonia of various microbiological aetiologies including two due to SARS, compared their PCT concentrations and provided further descriptors of SARS as a viral pneumonia. Results. Like any viral pneumonia, patients with SARS had low PCT levels in contrast to bacterial or fungal pneumonia. Conclusions. In the setting of pneumonia with a finding of low PCT, testing for SARS should be considered, especially if there is a positive travel or contact history. During a SARS epidemic, we also strongly advocate isolating all suspected community acquired pneumonia with a Low PCT level. © 2004 Published by Elsevier Ltd on behalf of The British Infection Society.||Source Title:||Journal of Infection||URI:||http://scholarbank.nus.edu.sg/handle/10635/117818||ISSN:||01634453||DOI:||10.1016/j.jinf.2004.01.015|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Jun 16, 2021
WEB OF SCIENCETM
checked on Jun 8, 2021
checked on Jun 19, 2021
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.